Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2005 3
2006 2
2007 2
2008 1
2009 2
2010 3
2011 3
2012 2
2013 4
2014 5
2015 5
2016 3
2017 3
2018 11
2019 10
2020 9
2021 8
2022 7
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Results by year

Filters applied: . Clear all
Page 1
Cell-Free DNA-Methylation-Based Methods and Applications in Oncology.
Galardi F, Luca F, Romagnoli D, Biagioni C, Moretti E, Biganzoli L, Leo AD, Migliaccio I, Malorni L, Benelli M. Galardi F, et al. Among authors: malorni l. Biomolecules. 2020 Dec 15;10(12):1677. doi: 10.3390/biom10121677. Biomolecules. 2020. PMID: 33334040 Free PMC article. Review.
Serum thymidine kinase activity in patients with HR-positive/HER2-negative advanced breast cancer treated with ribociclib plus letrozole: Results from the prospective BioItaLEE trial.
Malorni L, Bianchini G, Caputo R, Zambelli A, Puglisi F, Bianchi GV, Del Mastro L, Paris I, Montemurro F, Allegrini G, Colleoni M, Tamberi S, Zamagni C, Cazzaniga ME, Orditura M, Guarneri V, Castelletti D, Benelli M, Di Marino M, Arpino G, De Laurentiis M. Malorni L, et al. Eur J Cancer. 2023 Jun;186:1-11. doi: 10.1016/j.ejca.2023.03.001. Epub 2023 Mar 8. Eur J Cancer. 2023. PMID: 37003098 Free article. Clinical Trial.
The role of abemaciclib in treatment of advanced breast cancer.
McCartney A, Moretti E, Sanna G, Pestrin M, Risi E, Malorni L, Biganzoli L, Di Leo A. McCartney A, et al. Among authors: malorni l. Ther Adv Med Oncol. 2018 May 31;10:1758835918776925. doi: 10.1177/1758835918776925. eCollection 2018. Ther Adv Med Oncol. 2018. PMID: 29899762 Free PMC article. Review.
Selective CDK7 inhibition suppresses cell cycle progression and MYC signaling while enhancing apoptosis in therapy-resistant estrogen receptor positive breast cancer.
Guarducci C, Nardone A, Russo D, Nagy Z, Heraud C, Grinshpun A, Zhang Q, Freelander A, Leventhal MJ, Feit A, Cohen Feit G, Feiglin A, Liu W, Hermida-Prado F, Kesten N, Ma W, De Angelis C, Morlando A, O'Donnell M, Naumenko S, Huang S, Nguyen QD, Huang Y, Malorni L, Bergholz Villafane JS, Zhao JJ, Fraenkel E, Lim E, Schiff R, Shapiro GI, Jeselsohn R. Guarducci C, et al. Among authors: malorni l. Clin Cancer Res. 2024 Feb 21. doi: 10.1158/1078-0432.CCR-23-2975. Online ahead of print. Clin Cancer Res. 2024. PMID: 38381406
Precision Oncology via NMR-Based Metabolomics: A Review on Breast Cancer.
Vignoli A, Risi E, McCartney A, Migliaccio I, Moretti E, Malorni L, Luchinat C, Biganzoli L, Tenori L. Vignoli A, et al. Among authors: malorni l. Int J Mol Sci. 2021 Apr 28;22(9):4687. doi: 10.3390/ijms22094687. Int J Mol Sci. 2021. PMID: 33925233 Free PMC article. Review.
New approaches for improving outcomes in breast cancer in Europe.
Di Leo A, Curigliano G, Diéras V, Malorni L, Sotiriou C, Swanton C, Thompson A, Tutt A, Piccart M. Di Leo A, et al. Among authors: malorni l. Breast. 2015 Aug;24(4):321-30. doi: 10.1016/j.breast.2015.03.001. Epub 2015 Mar 31. Breast. 2015. PMID: 25840656 Free article. Review.
89 results